Close

BioTelemetry (BEAT) Tops Q3 EPS by 3c

November 2, 2016 4:35 PM EDT

BioTelemetry (NASDAQ: BEAT) reported Q3 EPS of $0.21, $0.03 better than the analyst estimate of $0.18. Revenue for the quarter came in at $53.1 million versus the consensus estimate of $52.92 million.

For earnings history and earnings-related data on BioTelemetry (BEAT) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings